Study Stopped
Closed with the IRB due to slow enrollment during COVID. Will be modifying the study with a new submission.
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
Effectiveness of Combined Attention and Metacognitive-strategy Training Approaches to Cognitive Impairment in Moderate-to-severe TBI
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this research study is to develop a method to improve thinking difficulties in individuals who have experienced a traumatic brain injury and report experiencing difficulties in attention and concentration. This study aims to understand how cognitive rehabilitation of attention difficulties affects brain activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2019
CompletedFirst Posted
Study publicly available on registry
December 13, 2019
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 17, 2021
CompletedNovember 22, 2021
November 1, 2021
16 days
December 12, 2019
November 15, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Measurement of change in self-care
These will be measured via the Timed Instrumental Activities of Daily Living assessment. Participants will be timed performing common functional tasks and longer completion times indicate greater impairment.
Measured at Baseline, Post treatment 1 (4 weeks post-baseline), Post treatment 2 (8 weeks post baseline)
Measurement of change in ability, adjustment and participation
A composite self-report questionnaire known as the Mayo-Portland Adaptability Inventory will be used to measure functioning across these domains. This measures uses a scale from 0 to 4. The higher the score the more severe the impairment.
Measured at Baseline, Post treatment 1 (4 weeks post-baseline), Post treatment 2 (8 weeks post baseline)
Study Arms (3)
Intervention Group 1
EXPERIMENTALThis arm will receive BrainHQ for the first four weeks of the study, and Goal Management Training for the second four weeks.
Intervention Group 2
EXPERIMENTALThis arm will receive Goal Management Training for the first four weeks of the study, and BrainHQ for the second four weeks.
Treatment-as-usual
NO INTERVENTIONInterventions
BrainHQ is a web-based "brain-training" program. The investigators will assign participants to attention specific modules that they will complete at home with the goal of "restoring" attentional functions lost through injury via repetitive tasks of graded difficulty.
This is a manualized, interactive, metacognitive-strategy training designed to promote a mindful approach to complex real-life tasks and reduce lapses in attention via implementation of "compensatory" mechanisms for monitoring tasks.
Eligibility Criteria
You may qualify if:
- Self-report of attention problems, confirmed with psychometric testing
- Ruff 2 \& 7 selective attention task score ≤ 1.5 standard deviations from demographically-matched norms
- Able to participate in study at 12-60 months post-injury without contraindications
- Willingness to be randomized and to participate in treatment procedures
- Capacity to visit the laboratory for repeated treatment sessions and testing
- Access to internet-enabled home computer
- English as native language
- Adequate reading comprehension to allow completion of questionnaires
- Reliable digit span (RDS) score \> 7
You may not qualify if:
- Pre-existing neurological disorder associated with cerebral dysfunction (e.g., stroke, history of epilepsy or chronic seizure disorder)
- Current alcohol or drug use
- Pre-existing severe psychiatric disorder (e.g., schizophrenia) detected by Mental Screening form, 3rd edition (MHS-III) or history of psychiatric diagnosis sufficiently severe to have resulted in inpatient hospitalization
- Current suicidal/homicidal ideation or intent
- Reported involvement in current litigation
- Reported history of pre-injury learning disability
- Not competent to provide written informed consent (i.e., not able to demonstrate understanding or expectations of study and potential risks of participation)
- Does not fully understand the nature of the study and requirements of participation
- Does not understand task instructions
- Validity testing (score ≤ 7) on the RDS 22 test of suboptimal/non-credible performance taken from the forward and backward digit span subtests of the WAIS-IV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Public Health and Health Professions, University of Florida
Gainesville, Florida, 32611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2019
First Posted
December 13, 2019
Study Start
September 1, 2021
Primary Completion
September 17, 2021
Study Completion
September 17, 2021
Last Updated
November 22, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share